NYSE International 100
8.491,13
PKT
+55,40
PKT
+0,66
%
Werbung
Analysen zu NYSE International 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.02.22 | Orange Neutral | Credit Suisse Group | |
18.02.22 | Allianz Kaufen | DZ BANK | |
18.02.22 | GSK Neutral | UBS AG | |
18.02.22 | AstraZeneca Buy | UBS AG | |
18.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
18.02.22 | Allianz Buy | UBS AG | |
18.02.22 | Eni Buy | Goldman Sachs Group Inc. | |
18.02.22 | Telefonica Buy | Deutsche Bank AG | |
18.02.22 | Eni Buy | Jefferies & Company Inc. | |
18.02.22 | Orange Buy | Deutsche Bank AG | |
18.02.22 | Eni Overweight | JP Morgan Chase & Co. | |
18.02.22 | Allianz Buy | Deutsche Bank AG | |
18.02.22 | Nutrien (Ex Potash Agrium) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
18.02.22 | Eni Outperform | RBC Capital Markets | |
18.02.22 | Allianz Buy | Jefferies & Company Inc. | |
18.02.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
18.02.22 | Siemens Underweight | Barclays Capital | |
18.02.22 | Nutrien (Ex Potash Agrium) Overweight | Barclays Capital | |
18.02.22 | Orange Neutral | JP Morgan Chase & Co. | |
18.02.22 | Allianz Neutral | JP Morgan Chase & Co. | |
17.02.22 | Eni Outperform | RBC Capital Markets | |
17.02.22 | Novartis Neutral | UBS AG | |
17.02.22 | Siemens Buy | UBS AG | |
17.02.22 | Orange Neutral | JP Morgan Chase & Co. | |
17.02.22 | Mercedes-Benz Group (ex Daimler) Outperform | Credit Suisse Group | |
16.02.22 | Eni Overweight | JP Morgan Chase & Co. | |
16.02.22 | Prudential Buy | UBS AG | |
16.02.22 | AstraZeneca Buy | UBS AG | |
16.02.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
16.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
15.02.22 | ING Group Equal-weight | Morgan Stanley | |
15.02.22 | Deutsche Bank Equal-weight | Morgan Stanley | |
15.02.22 | Santander Equal-weight | Morgan Stanley | |
15.02.22 | BBVA Overweight | Morgan Stanley | |
15.02.22 | Unilever Hold | Deutsche Bank AG | |
15.02.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.02.22 | AstraZeneca Overweight | Barclays Capital | |
15.02.22 | Unilever Buy | Jefferies & Company Inc. | |
15.02.22 | AXA Buy | Goldman Sachs Group Inc. | |
15.02.22 | Unilever Sector Perform | RBC Capital Markets |